Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBSYS for Breakthrough Cancer Pain
NCT00538850Phase 3Completed
- Sponsor
- Insys Therapeutics
- Start
- Oct 2007
- Primary completion
- Feb 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in breakthrough cancer pain (BTcP), sponsored by Insys Therapeutics. Started Oct 2007; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on NCT00538850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538850.